Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
1 - 14 out of 14Page size: 100
  1. 2009
  2. Published

    Incretin-based therapies: viewpoints on the way to consensus

    Nauck, M. A., Vilsbøll, Tina, Gallwitz, B., Garber, A. & Madsbad, Sten, 1 Nov 2009, In: Diabetes Care. 32 Suppl 2, p. S223-31

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men

    Pilgaard, K., Jensen, C., Schou, J., Lyssenko, V., Wegner, L., Brøns, C., Vilsbøll, T., Hansen, T., Madsbad, S., Holst, J., Vølund, A., Poulsen, P., Groop, L., Pedersen, O., Vaag, A., Pilgaard, K., Jensen, C. B., Schou, J. H., Lyssenko, V., Wegner, L. & 10 others, Brøns, C., Vilsbøll, T., Hansen, T., Madsbad, Sten, Holst, J. M., Vølund, A., Poulsen, P., Groop, L., Pedersen, O. & Vaag, A., 1 Jul 2009, In: Diabetologia. 52, 7, p. 1298-307 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Glucagon-like peptide-1 and diabetes treatment

    Vilsbøll, Tina, Hare, K., Bagger, J. O. & Knop, Filip Krag, 2009, In: International Diabetes Monitor. 21, p. 1-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Incretin hormones and diabetes mellitus

    Vilsbøll, Tina, Knop, Filip Krag, Deacon, Carolyn F. & Holst, Jens Juul, 2009, Therapeutic Strategies in Diabetes. Stehouwer, C. D. A. & Schaper, N. (eds.). Oxford: Clinical Publishing, p. 99-114

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research

  6. Published

    Incretin-based therapy of type 2 diabetes mellitus

    Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 2009, In: Current Protein and Peptide Science. 10, 1, p. 46-55 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

    Giugliano, D., Standl, E., Vilsbøll, Tina, Betteridge, J., Bonadonna, R., Campbell, I. W., Schernthaner, G., Staels, B., Trichopoulou, A. & Farinaro, E., 2009, In: Acta Diabetologica. 46, 3, p. 173-81 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide (GIP) in patients with type 2 diabetes

    Aaboe, K., Knop, Filip Krag, Vilsbøll, Tina, Vølund, A., Simonsen, U., Deacon, Carolyn F., Madsbad, Sten, Holst, Jens Juul & Krarup, T., 2009, In: Journal of Clinical Endocrinology and Metabolism. 94, 2, p. 603-608

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Liraglutide: a human GLP-1 analog for Type 2 diabetes

    Vilsbøll, Tina, 2009, In: Therapy. 6, 2, p. 199-207 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Liraglutide: a new treatment for type 2 diabetes

    Vilsbøll, Tina, 2009, In: Drugs of Today. 45, 2, p. 101-13 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

    Hare, K. J., Knop, Filip Krag, Asmar, M., Madsbad, Sten, Deacon, Carolyn F., Holst, Jens Juul & Vilsbøll, Tina, 2009, In: Journal of Clinical Endocrinology and Metabolism. 94, 12, p. 4679-87 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    The effects of glucagon-like peptide-1 on the beta cell

    Vilsbøll, Tina, 2009, In: Diabetes, Obesity and Metabolism. 11 Suppl 3, p. 11-18 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

    Vilsbøll, Tina, Holst, Jens Juul & Knop, Filip Krag, 2009, In: Best Practice & Research: Clinical Endocrinology & Metabolism. 23, 4, p. 453-62 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, 2009, In: International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

    Aaboe, K., Knop, F. K., Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2009, In: Diabetologia. p. 748

    Research output: Contribution to journal › Conference abstract in journal › Research

ID: 33056950